Appropriate screening intervals in low-dose CT lung cancer screening

Area of Science:

• Pulmonology
• Radiology
• Oncology

Background:

• Lung cancer screening with low-dose chest CT (LDCT) is expanding in the US and Europe.
• Current programs often recommend annual LDCT, but this frequency lacks biological basis.
• A personalized approach to screening is crucial for balancing benefits and harms.

Purpose of the Study:

• To evaluate the feasibility of tailored screening intervals in lung cancer screening programs.
• To identify participants who can safely undergo less frequent screening.
• To reduce potential harms like radiation exposure and costs associated with annual screening.

Main Methods:

• Analysis of baseline screening results from randomized controlled lung cancer screening studies.
• Identification of participants with a low 2-year lung cancer probability.
• Assessment of safety for prolonged screening intervals in this low-risk subset.

Main Results:

• Baseline screening results can identify individuals with a low probability of developing lung cancer within 2 years.
• These low-risk participants can be safely monitored with extended screening intervals, potentially 1-2 years.
• Participants with new or growing pulmonary nodules require a return to annual screening.

Conclusions:

• Tailored lung cancer screening intervals based on individual risk are feasible and beneficial.
• Prolonged screening intervals for low-risk individuals can decrease radiation exposure, costs, and potential harms.
• Risk stratification using baseline LDCT is key to optimizing lung cancer screening programs.